Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy
Enrolling by invitation · Phase 2 · Has a placebo group
Conditions studied: Oral Mucositis, Head and Neck Cancer (H&N), Radiotherapy Side Effects
In brief
Patients receiving radiotherapy for head and neck cancer often develop oral mucositis, a painful condition that causes redness and sores in the mouth. Oral mucositis can make it difficult to eat, drink, and speak, and may interfere with cancer treatment. Some viruses from the herpesvirus family, which commonly remain inactive in the body, may become active during cancer treatment and worsen mouth sores. However, the role of these viruses in oral mucositis is not fully understood. This study aims to understand whether herpesviruses present in the mouth are associated with the development and severity of oral mucositis in adults receiving radiotherapy for head and neck cancer. The study also evaluates whether taking an antiviral medication (valacyclovir) can reduce viral activity and improve mouth symptoms during treatment. Participants are randomly assigned to receive either valacyclovir or a placebo while undergoing radiotherapy. Samples from the mouth and saliva are collected at different time points before, during, and after radiotherapy to detect herpesviruses. Mouth sores are regularly examined, and pain levels are recorded throughout treatment. The results of this study may help clarify the role of herpesviruses in oral mucositis and support better strategies to prevent or manage this condition in patients receiving radiotherapy for head and neck cancer.
Key facts
- Study ID
- NCT07363031
- Run by
- Instituto Oncoclinicas
- People needed
- 84
- Starts
- 2022-09-05
- Expected to finish
- 2026-10-01
- Last updated by the study team
- 2026-01-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults aged 18 years or older.
- Diagnosis of head and neck cancer.
- Planned to receive curative or definitive radiotherapy to the head and neck region.
- Ability to swallow oral medication.
- Adequate clinical condition to participate in study procedures.
- Ability to provide written informed consent.
You may not qualify if…
- Known hypersensitivity or contraindication to valacyclovir or related antiviral agents.
- Current or recent use of systemic antiviral therapy.
- Severe renal impairment requiring dose adjustment or contraindicating valacyclovir use.
- Active oral infection requiring systemic antimicrobial treatment at baseline.
- Pregnant or breastfeeding individuals.
- Participation in another interventional clinical trial that may interfere with study outcomes.
Where it is running
- Instituto Oncoclinicas — Rio de Janeiro, Rio de Janeiro, Brazil
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.